Actively Recruiting

Phase Not Applicable
Age: 22Years - 79Years
All Genders
NCT04883411

CEM-Plate and CEM-Cage First-In-Human Use Efficacy Study

Led by ReVivo Medical, Corp. · Updated on 2025-04-18

50

Participants Needed

4

Research Sites

299 weeks

Total Duration

On this page

Sponsors

R

ReVivo Medical, Corp.

Lead Sponsor

A

Albany Medical College

Collaborating Sponsor

AI-Summary

What this Trial Is About

The study is a prospective, first-in-human, multi-center, non-randomized, single-arm study to assess the safety and efficacy of the CEM-Cage used with the CEM-Plate in patients who are appropriate candidates for a 2-level anterior cervical discectomy and fusion (ACDF). Fifty patients will be enrolled in the study and, after undergoing a 2-level ACDF, will be evaluated at 4 weeks, 3 months, 6 months, 12 months, 18 months, and 24 months.

CONDITIONS

Official Title

CEM-Plate and CEM-Cage First-In-Human Use Efficacy Study

Who Can Participate

Age: 22Years - 79Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Males and females aged 22-79 years
  • Diagnosed with cervical spine radiculopathy or myelopathy
  • Symptomatic cervical degenerative disc disease at 2 contiguous levels between C2 through T1
  • Baseline Neck Disability Index (NDI) score of 30 or higher and/or modified Japanese Orthopaedic Association (mJOA) score of 16 or lower
  • Imaging confirms pathology at the treated level correlating with symptoms
  • Unresponsive to at least 6 weeks of conservative treatment or have progressive myelopathy or signs of nerve/spinal cord compression despite treatment
  • Able to understand, speak, and read the informed consent document
  • Willing to provide informed consent to participate
Not Eligible

You will not qualify if you...

  • Prior cervical surgeries or fusion at the symptomatic levels
  • Treatment required at fewer or more than 2 vertebral levels
  • Anatomy unsuitable for receiving the investigational device
  • More than one immobile vertebral level between C1 and C7 from any cause
  • Known osteoporosis or current osteoporosis treatment that contraindicates surgery
  • Paget disease, osteomalacia, or other metabolic bone diseases aside from osteoporosis
  • Active or recent invasive malignancy (except certain skin cancers) unless treated and symptom-free for over 5 years
  • Severe cervical instability requiring anterior and posterior procedures
  • Decompression needing corpectomy at one or more levels
  • Active infections systemically or at implant site
  • Open wounds or local inflammation
  • Fever
  • Conditions preventing accurate clinical evaluation
  • Daily or chronic use of high-dose oral or inhaled steroids
  • Body mass index over 40
  • Use of other investigational drugs or devices within 30 days prior to surgery
  • Smoking more than one pack of cigarettes per day
  • Mental illness preventing study participation
  • History or current substance abuse needing intervention
  • Legal issues related to spinal injury or worker's compensation
  • History or anticipated treatment for systemic infections including HIV or Hepatitis C
  • Previous trauma causing significant injury to C2 to T1 levels
  • Neck pain alone without radiculopathy or myelopathy symptoms needing surgery
  • Pregnancy
  • Medical or surgical conditions preventing benefit from spinal implant surgery
  • Known metal allergy or intolerance
  • Inadequate tissue coverage, bone stock, quality, or anatomical definition at operative site
  • Unwilling to follow post-operative instructions
  • Implant use interfering with anatomical or physiological function

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 4 locations

1

IGEA

Union, New Jersey, United States, 07083

Actively Recruiting

2

Albany Medical College

Albany, New York, United States, 12208

Actively Recruiting

3

University at Buffalo Neurosurgery

Williamsville, New York, United States, 14221

Actively Recruiting

4

Cleveland Clinic

Cleveland, Ohio, United States, 44195

Actively Recruiting

Loading map...

Research Team

E

Eric H Ledet, Ph.D.

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

CEM-Plate and CEM-Cage First-In-Human Use Efficacy Study | DecenTrialz